Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1997

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
Principles of method if other than guideline:
Method according to Schmid (1975) and McGregor (1980)
GLP compliance:
not specified
Type of assay:
mammalian erythrocyte micronucleus test

Test material

Constituent 1
Chemical structure
Reference substance name:
2,2'-methyliminodiethanol
EC Number:
203-312-7
EC Name:
2,2'-methyliminodiethanol
Cas Number:
105-59-9
Molecular formula:
C5H13NO2
IUPAC Name:
2-[(2-hydroxyethyl)(methyl)amino]ethan-1-ol

Test animals

Species:
mouse
Strain:
Swiss Webster
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: 6-8 weeks


Administration / exposure

Route of administration:
intraperitoneal
Duration of treatment / exposure:
single application
Frequency of treatment:
once
Post exposure period:
30, 48 and 72 hours
Doses / concentrationsopen allclose all
Dose / conc.:
175 mg/kg bw/day (nominal)
Dose / conc.:
350 mg/kg bw/day (nominal)
Dose / conc.:
560 mg/kg bw/day (nominal)
No. of animals per sex per dose:
5
Control animals:
yes, concurrent vehicle
Positive control(s):
triethylenemelamine
- Route of administration: i.p.
- Doses / concentrations: 0.3 mg/kg
- 30 h post dosing

Examinations

Tissues and cell types examined:
peripheral blood erythrocytes
Details of tissue and slide preparation:
CRITERIA FOR DOSE SELECTION:
based on pretest: about 80, 50 and 25 % of the LD50

DETAILS OF SLIDE PREPARATION:
Slides of blood smears were stained with Gurr's R-66 Giemsa diluted in phosphate buffer, coded and read without knowledge of treatment group to prevent bias.

METHOD OF ANALYSIS:
The polychromatic/normochromatic erythrocyte ratio for approximately 1000 total cells for each animal was calculated to provide an estimate of cytotoxicity.

Evaluation criteria:
A positive result was concluded if at least one statistical significant increase above vehicle control was an indication of a dose-related effect.
Statistics:
Data were compared for significant differences using the Fisher's Exact Test.

Results and discussion

Test results
Key result
Sex:
male/female
Genotoxicity:
negative
Toxicity:
no effects
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
There were no significant differences in the polychromatic erythrocyte to normochromatic erythrocyte ratios at any dosage. Furthermore, no significant increases in the incidence of micronucleated polychromatic erythrocyte were observed at any sampling time. Therefore, MDEA is not considered to be inducer of micronuclei under the condition of this in vivo test.

Any other information on results incl. tables

Induction of micronucleus in peripheral erythrocytes:

 Sex  Mean PCE/1000 NCE (±SD)            
   Water  TEM  MDEA (mg/kg)      
       175  350  560
30 h postdosing          
  Male  52±24  36±8  55±17  64±11  70±12
  Female  35±10  36±9  41±8  48±9  41±14
48 h postdosing          
  Male  43±13    45±17  43±12  36±4
  Female  31±6    34±18  32±12  38±4
72 h postdosing          
  Male  39±7    38±12  36±14  32±14
  Female  32±9    31±11  39±9  24±7

 Sex  Mean MN-PCE/1000 NCE (±SD)            
   Water  TEM  MDEA (mg/kg)      
       175  350  560
30 h postdosing          
  Male  5.4±3.2  42.0±8 b  4.8±2.4  6.6±2.9 4.8±3.5 
  Female  2.6±1.7  43±15 b  4.2±2.8  3.0±0.7  1.6±1.5
48 h postdosing          
  Male  3.8±3.1   4.2±2.8   5.0±4.4  3.0±2.0
  Female  2.4±1.5    3.8±2.4  2.2±1.3  2.6±2.7
72 h postdosing          
  Male  5.0±2.0    2.6±2.1  7.0±5.6  2.7±1.2
  Female  3.2±1.1   2.2±1.3   3.0±2.8  2.8±1.9

There were no significant differences in the polychromatic erythrocyte to normochromatic erythrocyte ratios at any dosage. Furthermore, no significant increases in the incidence of micronucleated polychromatic erythrocyte were observed at any sampling time. Therefore, MDEA is not considered to be inducer of micronuclei under the condition of this in vivo test.

Applicant's summary and conclusion